日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Detection of S1 spike protein in CD16+ monocytes up to 245 days in SARS-CoV-2-negative post-COVID-19 vaccine syndrome (PCVS) individuals.

在SARS-CoV-2阴性的COVID-19疫苗后综合征（PCVS）患者中，CD16+单核细胞中S1刺突蛋白的检测时间长达245天。

期刊:Human Vaccines & Immunotherapeutics
影响因子:3.5
doi:10.1080/21645515.2025.2494934
Patterson Bruce K, Yogendra Ram, Francisco Edgar B, Guevara-Coto Jose, Long Emily, Pise Amruta, Osgood Eric, Bream John, Kreimer Mark, Jeffers Devon, Beaty Christopher, Vander Heide Richard, Mora-Rodríguez Rodrigo A
SARS-CoV-2
CD16
细胞生物学
单核细胞
发表日期：2025
文献求助 收藏

Corrigendum: Case Series: Maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequalae of COVID (PASC)

更正：病例系列：马拉维罗和普伐他汀作为治疗新冠长期症状/新冠后急性期后遗症（PASC）的治疗选择

期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2024.1375607
Patterson, Bruce K; Yogendra, Ram; Guevara-Coto, Jose; Mora-Rodriguez, Rodrigo A; Osgood, Eric; Bream, John; Parikh, Purvi; Kreimer, Mark; Jeffers, Devon; Rutland, Cedric; Kaplan, Gary; Zgoda, Michael
微生物学
新冠
ASC
发表日期：2024
文献求助 收藏

Case series: Maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequelae of COVID (PASC)

病例系列：马拉维罗和普伐他汀作为治疗新冠长期症状/新冠后急性期后遗症（PASC）的治疗选择

期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2023.1122529
Patterson, Bruce K; Yogendra, Ram; Guevara-Coto, Jose; Mora-Rodriguez, Rodrigo A; Osgood, Eric; Bream, John; Parikh, Purvi; Kreimer, Mark; Jeffers, Devon; Rutland, Cedric; Kaplan, Gary; Zgoda, Michael
微生物学
新冠
ASC
发表日期：2023
文献求助 收藏

Neural tissue co-culture with mesenchyme to investigate patterningof peripheral nerve during murine embryonic limb development.

将神经组织与间充质共培养，以研究小鼠胚胎肢体发育过程中周围神经的模式形成

期刊:Cytotechnology
影响因子:1.7
doi:10.1007/s10616-005-3099-2
Todd Richmond A, Atwood Justin, Bream John, Mjaatvedt Corey H, Hoffman Stanley, Capehart Anthony A
神经科学
发表日期：2004
文献求助 收藏